{"id":"W2890521724","doi":"10.1016/j.jtho.2018.07.026","title":"PD.1.01 Health-Related Quality of Life with Pembrolizumab or Placebo + Pemetrexed + Platinum in Non-Squamous NSCLC: KEYNOTE-189","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pemetrexed; Pembrolizumab; Medicine; Placebo; Internal medicine; Carboplatin; Quality of life (healthcare); Oncology; Cisplatin; Chemotherapy; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008453046,0.0004741152,0.0009884777,0.0001800125,0.0002114269,0.0006538386,0.0004410294,0.0005661473,0.02093296],"category_scores_gemma":[0.0007783567,0.0002110021,0.0019057,0.0001982608,0.0002377554,0.0004538861,0.000369661,0.002212311,0.001313091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004748029,"about_ca_system_score_gemma":0.0007958331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008321307,"about_ca_topic_score_gemma":0.001800137,"domain_scores_codex":[0.9997397,0.000102259,0.0000162878,0.00003352002,0.00003492548,0.00007320572],"domain_scores_gemma":[0.9997625,0.00008975428,0.00004109117,0.00001373476,0.00002019108,0.00007275062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7563463,0.00593367,0.002961235,0.002612968,0.002024493,0.00008014507,0.00004255742,0.0008181267,0.006192863,0.000809367,0.03284204,0.1893361],"study_design_scores_gemma":[0.6982161,0.1610267,0.0749766,0.0009644561,0.005441943,0.0002748208,0.0001115367,0.00178902,0.005303239,0.001919268,0.04991652,0.00005982578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.804543,0.06501775,0.002279501,0.01712737,0.007473755,0.004434658,0.0242114,0.0006711007,0.07424141],"genre_scores_gemma":[0.934542,0.01837753,0.003730142,0.005376622,0.002238804,0.004012861,0.008742243,0.00006217659,0.02291759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02093296,"threshold_uncertainty_score":0.07002765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04196411465326621,"score_gpt":0.4600915825657306,"score_spread":0.4181274679124644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}